Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Testosterone

Genital tracts

The internal and external genitalia of both sexes are genetically ‘programmed’ to differentiate passively down a ‘default’  female pathway unless actively switched down a male pathway by the genetic information carried by the testis-determining gene (SRY).  Until the sixth week of gestation,  the genitalia of both sexes share identical embryonic precursors.  Differentiation   of… Genital tracts   



70 percent of prostate cancer patients on ADT gain significant weight in first year

Seventy per cent of men who received androgen-deprivation therapy (ADT) after surgery to remove their prostate gland gained significant weight in the first year, putting on an average of 4.2kg, according to a paper in the March issue of the urology journal BJUI.

Researchers studied the recorded weights of 132 men who underwent radical… 70 percent of prostate cancer patients on ADT gain significant weight in first year   



Study Compares Timing of Hormonal Therapy for Prostate Cancer

Men with metastatic prostate cancer who undergo hormone-deprivation therapy sometimes take breaks from the treatment to minimize its often difficult side effects.

However, a major new study that tracked more than 1,500 men for almost a decade finds that opting for intermittent treatment may take a toll on certain patients, in terms of shortened… Study Compares Timing of Hormonal Therapy for Prostate Cancer   



Like prostate cancer, bladder cancer patients may benefit from anti-androgen therapy

Bladder cancer patients whose tumors express high levels of the protein CD24 have worse prognoses than patients with lower CD24. A University of Colorado Cancer Center study published today in the Proceedings of the National Academy of Sciences shows that CD24 expression may depend on androgens – and that anti-androgen therapies like those currently… Like prostate cancer, bladder cancer patients may benefit from anti-androgen therapy   



Mushroom-supplemented soybean extract shows therapeutic promise for advanced prostate cancer

A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found.

Men with prostate cancer that has spread to other parts of the body, known as metastatic cancer, and who have had their… Mushroom-supplemented soybean extract shows therapeutic promise for advanced prostate cancer   



Low testosterone levels may indicate worsening of disease for men with prostate cancer

For men with low-risk prostate cancer, low levels of testosterone may indicate a worsening of their disease. That’s the conclusion of a new study published in BJU International. The findings may help physicians identify patients with low-risk prostate cancer who should receive aggressive anticancer treatment.

Men with prostate cancer that is not life threatening… Low testosterone levels may indicate worsening of disease for men with prostate cancer   



ohsu knight cancer institute1 - urethral diverticulum1 - dstyk1 - ultrasound examination1 - prostate cells1 - radium-223 chloride1 - pediatric kidney failure1 - bss1 - diarrhea1 - jevtana1 - larry greenbaum1 - ectopic pregnancy2 - high-grade prostate cancer1 - mitotane1 - psa tests1 - plco trial1 - stone disease prevention1 - sex life1 - x-ray1 - special la coke1 - risk of stone1 - sex therapy1 - dry mouth1 - thrombotic thrombocytopenic purpura1 - urinary tract dysfunction1 - bladder frequency1 - urinary stasis1 - urological diseases1 - journal of urology5 - urethral hypermobility4 -